15,572
Total Claims
$2.8M
Drug Cost
1,672
Beneficiaries
$1,671
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+10%
Cost per patient vs peers
$1,671 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 13,064 claims · $303K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,491 | $1.6M |
| Rivaroxaban | 337 | $359K |
| Sacubitril/Valsartan | 118 | $147K |
| Evolocumab | 148 | $124K |
| Alirocumab | 64 | $54K |
| Metoprolol Succinate | 1,428 | $33K |
| Atorvastatin Calcium | 1,415 | $19K |
| Ticagrelor | 26 | $19K |
| Diltiazem Hcl | 337 | $19K |
| Dofetilide | 87 | $18K |
| Rosuvastatin Calcium | 934 | $14K |
| Ranolazine | 128 | $14K |
| Ivabradine Hcl | 16 | $12K |
| Ezetimibe | 346 | $12K |
| Flecainide Acetate | 129 | $11K |
Prescribing Profile
65
Unique Drugs
$2.1M
Patient Profile
77
Avg Age
41%
Female
1.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data